Literature DB >> 2963865

Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset.

A Tishon1, P J Southern, M B Oldstone.   

Abstract

Viruses that cause in vivo persistent infections need to selectively compromise the host's immunologic surveillance machinery in order to survive. To understand the molecular basis of how this is accomplished we have analyzed persistent virus infection by lymphocytic choriomeningitis in its normal host, the mouse. Earlier we noted by infectious center analysis that five in 10(4) lymphocytes carried by persistently infected mice contained infectious materials throughout the course of infection. A previous publication extended these results, in BALB mice by showing that the L3T4+ lymphocyte subset in lymph nodes and spleens was predominantly involved. Using cDNA labeled probes to the viral genome and in situ hybridization we report that 1 to 2% of circulating lymphocytes from several mouse strains contain viral RNA sequences for the three viral structural genes. By FACS analysis, the Thy-1.2+, L3T4+ subset primarily harbors virus while viral sequences are usually not detected in the Lyt-2+ subset as early as 6 days after initiating infection in newborns and throughout the course of the persistence. These findings suggest that incomplete, presumably defective, virus is generated in a subset of Th lymphocytes during persistent infection and that during this time infection of cytotoxic T cell subsets is minimal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2963865

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

Authors:  B Odermatt; M Eppler; T P Leist; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

2.  Dynamics of cytotoxic T-lymphocyte exhaustion.

Authors:  D Wodarz; P Klenerman; M A Nowak
Journal:  Proc Biol Sci       Date:  1998-02-07       Impact factor: 5.349

3.  Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.

Authors:  D Moskophidis; H Pircher; I Ciernik; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo.

Authors:  J Dockter; C F Evans; A Tishon; M B Oldstone
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Lymphocytic choriomeningitis virus-induced immune dysfunction: induction of and recovery from T-cell anergy in acutely infected mice.

Authors:  E A Butz; P J Southern
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses.

Authors:  J M McNally; C C Zarozinski; M Y Lin; M A Brehm; H D Chen; R M Welsh
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Viral infection of the thymus.

Authors:  C C King; B D Jamieson; K Reddy; N Bali; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.

Authors:  R C Hom; G Soman; R Finberg
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus.

Authors:  P Borrow; M B Oldstone
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands.

Authors:  Jillian M Rojek; Christina F Spiropoulou; Kevin P Campbell; Stefan Kunz
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.